{"id":"https://openalex.org/W7222503511","doi":"https://doi.org/10.1201/9781003632214-4","title":"Antimicrobial Precision in Critically Ill Neonatal and Paediatric Population","display_name":"Antimicrobial Precision in Critically Ill Neonatal and Paediatric Population","publication_year":2026,"publication_date":"2026-10-16","ids":{"openalex":"https://openalex.org/W7222503511","doi":"https://doi.org/10.1201/9781003632214-4"},"language":"en","primary_location":{"id":"doi:10.1201/9781003632214-4","doi":"https://doi.org/10.1201/9781003632214-4","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003632214-4","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibiotic Precision in Critically Ill Patients","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W7222448816","display_name":"Antibiotic Precision in Critically Ill Patients"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017868708","display_name":"Aparna Chakravarty","orcid":"https://orcid.org/0000-0002-7734-6144","observed_orcids":["https://orcid.org/0000-0002-7734-6144"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aparna Chakravarty","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5003939295","display_name":"Aleena Issac","orcid":"https://orcid.org/0000-0001-5686-6004","observed_orcids":["https://orcid.org/0000-0001-5686-6004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleena Issac","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.97066437,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"26","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.8945000171661377,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.8945000171661377,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0494999997317791,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.04540000110864639,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/critically-ill-neonates","display_name":"critically ill neonates","score":0.902999997138977},{"id":"https://openalex.org/keywords/critically-ill-children","display_name":"critically ill children","score":0.8230000138282776},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7139999866485596},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9520000219345093},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.8610000014305115},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9520000219345093},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.9660000205039978},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.9660000205039978},{"id":"https://openalex.org/keywords/microbiome-disruption","display_name":"microbiome disruption","score":0.7940000295639038},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.8270000219345093},{"id":"https://openalex.org/keywords/antimicrobial-de-escalation","display_name":"antibiotic de-escalation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/neonatal-intensive-care","display_name":"neonatal intensive care","score":0.7509999871253967},{"id":"https://openalex.org/keywords/pediatric-intensive-care","display_name":"pediatric intensive care","score":0.9829999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8349000215530396},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.8162999749183655},{"id":"https://openalex.org/C2991859549","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Critically ill","level":2,"score":0.6611999869346619},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.5533000230789185},{"id":"https://openalex.org/C2776040555","wikidata":"https://www.wikidata.org/wiki/Q19903321","display_name":"Antimicrobial stewardship","level":4,"score":0.5281999707221985},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4943999946117401},{"id":"https://openalex.org/C2909960733","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial drug","level":3,"score":0.4535999894142151},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4510999917984009},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45010000467300415},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.4327000081539154},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.42309999465942383},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.38190001249313354},{"id":"https://openalex.org/C2993568657","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Critical illness","level":3,"score":0.3573000133037567},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.34940001368522644},{"id":"https://openalex.org/C143121216","wikidata":"https://www.wikidata.org/wiki/Q1330402","display_name":"Microbiome","level":2,"score":0.34610000252723694},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.31060001254081726},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.3077999949455261},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.3061000108718872},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.27079999446868896},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.25839999318122864}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003632214-4","doi":"https://doi.org/10.1201/9781003632214-4","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003632214-4","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibiotic Precision in Critically Ill Patients","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Precision-guided":[0],"antimicrobial":[1,40,58,90],"therapy":[2],"in":[3,62,92],"critically":[4],"ill":[5],"neonatal":[6],"and":[7,20,29,36,47,57,64,71,88],"pediatric":[8,94],"populations":[9],"is":[10],"essential":[11],"due":[12],"to":[13,43],"unique":[14],"physiological":[15],"characteristics":[16],"affecting":[17],"drug":[18,48,53],"pharmacokinetics":[19],"pharmacodynamics.":[21],"Immature":[22],"organ":[23],"systems,":[24],"altered":[25],"volume":[26],"of":[27,51,73],"distribution,":[28],"dynamic":[30],"disease":[31],"states":[32],"necessitate":[33],"individualized":[34],"dosing":[35],"careful":[37],"monitoring.":[38],"Inappropriate":[39],"use":[41],"contributes":[42],"resistance,":[44],"microbiome":[45],"disruption,":[46],"toxicity.":[49],"Integration":[50],"therapeutic":[52],"monitoring,":[54],"evidence-based":[55],"dosing,":[56],"stewardship":[59],"improves":[60],"outcomes":[61],"NICU":[63],"PICU":[65],"settings.":[66],"Rational":[67],"selection,":[68],"timely":[69],"de-escalation,":[70],"avoidance":[72],"contraindicated":[74],"drugs":[75],"are":[76],"key":[77],"principles.":[78],"A":[79],"patient-centred,":[80],"precision":[81],"approach":[82],"optimizes":[83],"efficacy":[84],"while":[85],"minimizing":[86],"harm":[87],"combating":[89],"resistance":[91],"vulnerable":[93],"populations.":[95]},"counts_by_year":[],"updated_date":"2026-10-18T09:31:52.927876","created_date":"2026-10-17T00:00:00"}